Determine the necessary mass, volume, or concentration for preparing a solution.
m-PEG9-bromide is a PEG derivative containing a bromide group. The bromide (Br) is a very good leaving group for nucleophilic substitution reactions. The hydrophilic PEG spacer increases solubility in aqueous media.
Taxonomy Tree
| Kingdom | Organic compounds |
|---|---|
| Superclass | Organic oxygen compounds |
| 分類 | Organooxygen compounds |
| Subclass | Ethers |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Dialkyl ethers |
| Alternative Parents | Organobromides Hydrocarbon derivatives Alkyl bromides |
| Molecular Framework | Aliphatic acyclic compounds |
| Substituents | Dialkyl ether - Hydrocarbon derivative - Organobromide - Organohalogen compound - Alkyl halide - Alkyl bromide - Aliphatic acyclic compound |
| 説明 | This compound belongs to the class of organic compounds known as dialkyl ethers. These are organic compounds containing the dialkyl ether functional group, with the formula ROR', where R and R' are alkyl groups. |
| External Descriptors | Not available |
| 分子量 | 491.4 |
|---|---|
| XLogP3 | -0.300 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 26 |
| Exact Mass | 490.178 Da |
| Monoisotopic Mass | 490.178 Da |
| Topological Polar Surface Area | 83.100 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 288.000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| The total count of all stereochemical bonds | 0 |
| Covalently-Bonded Unit Count | 1 |
H302:Harmful if swallowed
H315:Causes skin irritation
H319:Causes serious eye irritation
H335:May cause respiratory irritation
P261:Avoid breathing dust/fume/gas/mist/vapors/spray.
P264:Wash hands [and …] thoroughly after handling.
P270:Do not eat, drink or smoke when using this product.
P271:Use only outdoors or in a well-ventilated area.
P280:Wear protective gloves/protective clothing/eye protection/face protection.
P321:Specific treatment (see ... on this label).
P330:Rinse mouth.
P302+P352:IF ON SKIN: wash with plenty of water.
P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing.
P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing.
P362+P364:Take off contaminated clothing and wash it before reuse.
P405:Store locked up.
P403+P233:Store in a well-ventilated place. Keep container tightly closed.
P501:Dispose of contents/container to an approved waste disposal plant.
P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes.
P301+P317:IF SWALLOWED: Get medical help.
P337+P317:If eye irritation persists: Get medical help.
P332+P317:If skin irritation occurs: Get medical help.
P319:Get medical help if you feel unwell.
No application protocols (e.g., WB, IHC, IF, FC) apply to this chemical reagent. For synthetic use, refer to the Reaction Conditions and Synthetic Utility sections for general, literature-based guidance. If you require a stepwise protocol for a specific transformation (e.g., azide substitution, Williamson ether formation, or ATRP macroinitiation), contact Technical Support with your substrate details to obtain a tailored, scale-appropriate procedure.
This product is a synthetic PEGylation building block rather than a biological macromolecule. The following notes describe general, research-level roles of PEG chains and PEGylation motifs; they are not medical/clinical claims.
For biological or biochemical conjugations, consider converting the –Br to more bio-orthogonal handles (e.g., azide for CuAAC, NHS carbonate for amine coupling) prior to exposure to complex biological media.
m-PEG9-bromide is not a buffering agent and does not constitute a defined acid/base pair for pH control. Consequently, it is not typically used to prepare or adjust biological or analytical buffers.
Practical note for researchers: If employing this reagent to modify surfaces or macromolecules that will ultimately be handled in buffers, conduct the alkylation or end-group conversion in suitable anhydrous organic media. After reaction and purification, transfer the PEGylated product to buffer. For aqueous bioconjugation workflows, convert the bromide to a more compatible handle (e.g., azide, NHS, maleimide) before performing reactions in phosphate, HEPES, or other biological buffers.
Selecting greener strategies with m-PEG end-group chemistry centers on both the leaving group and the solvent system.
Leaving group considerations:
Solvent selection (greener media vs. conventional):
Greener choice | Conventional | Comment (literature/general) ---------------|-------------|------------------------------ 2-MeTHF | THF | Bio-based, higher bp, moisture tolerant; good for K2CO3-mediated SN2. CPME | Dioxane | Low peroxide tendency; broader safety envelope. MeCN (ACS GPC) | DMF/DMSO | Easier removal, lower toxicity; may require higher temperature. Propylene carbonate | CH2Cl2 | High dielectric, non-volatile; viscosity can slow mass transfer. Ethyl acetate | CH2Cl2 | Useful for extractions and some PTC systems.
Process tips:
Tradeoffs: Highly polar aprotic solvents (DMF/DMSO) often deliver the fastest SN2 rates; greener alternatives may require longer times or elevated temperature. Optimize on small scale before scale-up.
No therapeutic or clinical claims are made. The information below concerns research/formulation contexts only.
Item-specific physicochemical specifications are not provided. The following notes reflect general/literature characteristics of short mPEG bromides; confirm exact values on the CoA/Spec Sheet for SKU M595488.
m-PEG9-bromide is a versatile electrophile used to introduce a hydrophilic, methoxy-terminated PEG spacer onto nucleophilic substrates and to initiate controlled radical polymerizations.
The following conditions are representative literature/general practices for m-PEG alkyl bromides; optimize per substrate.
General tips:
As an electrophilic mPEG reagent used primarily in SN2 and initiation chemistries, solvent choice should balance nucleophile solvation, substrate solubility, and suppression of side reactions.
m-PEG9-bromide is a monofunctional polyethylene glycol (PEG) oligomer bearing a terminal alkyl bromide and a methoxy-terminated opposite end, enabling SN2-type alkylation chemistry while retaining PEG’s solubilizing, hydrophilic character.
Not applicable. This product is a small-molecule/oligomeric reagent (m-PEG9-bromide) and is not an antibody, protein, or assay-directed probe. It does not possess biological “target specificity” parameters such as antigen, epitope, clone, isotype, or species reactivity.